Zealand Pharma Announces FDA Approval of Zegalogue (dasiglucagon)
Zealand Pharma announced on March 22, that the U.S. Food and Drug Administration (FDA) has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia…
Zealand Pharma announced on March 22, that the U.S. Food and Drug Administration (FDA) has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia…
The AstraZeneca’s AZD1222 US Phase III Trial demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease…
On March 15, the Centers for Medicare & Medicaid Services (CMS) is increasing the Medicare payment amount for administering the COVID-19 vaccine.“This new and higher…
The Centers for Disease Control and Prevention (CDC), on March 17, announced a plan to invest $2.25 billion over two years to address Coronavirus Disease…
On March 17, the U.S. Food and Drug Administration (FDA) granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), the first SARS-CoV-2 diagnostic test…
On March 17, Walmart announced to the media about new access to digital health records, beginning with their COVID-19 vaccine record“As a healthcare services provider,…
The FDA, along with the CDC and the Southern Nevada Health District is investigating a number of reports of acute non-viral hepatitis in the state…
CVS Health, on March 16, announced the availability of COVID-19 antibody testing in all MinuteClinic locations in Massachusetts, there are nearly 60 MinuteClinic locations in…
On March 15, Walgreens announced that it will participate in the first-ever Localization Summit, a virtual showcase for diverse, local and regional businesses and entrepreneurs…
Recently the National Community Pharmacists Association (NCPA) released a new survey, according to which, Americans shows a strong preference to receive the COVID-19 vaccines from…